Me’s genetic data may be for sale after bankruptcy. AI firms may want in—but privacy fears could make it a toxic asset.

Guardrails are essential to ensure AI serves the purpose of innovative care delivery models without unintended consequences.

A phylogenetic tree of SARS-CoV-2 sequences, built with Nextstrain, displays sequences colored by their clade and organized by collection date. Over time, sequences mutate and diverge, forming new ...

Cedars-Sinai investigators have developed a novel artificial intelligence (AI) model, named DYNA, that accurately ...

Building the world's largest biobank with data from global populations to accelerate biomarker and drug discovery and ...

Genetics testing company 23andMe has filed for Chapter 11 bankruptcy—and the possible impact of this move on data privacy has ...

The start of 23andMe Holding Co.'s closely watched bankruptcy proceedings offers customers a troubling reminder of their ...

While I see generative AI emerging as healthcare’s most transformative disruptor, its full potential relies on robust data ...

If we are willing to accept the need for IP protection, like most other farmers around the world, then we have a chance to ...

In today’s rapidly evolving technological landscape, the application of intelligent systems is profoundly altering various sectors, with healthcare emerging as a primary beneficiary. Solutions powered ...

Finally, the widespread deployment of AI will catalyze change in almost every aspect of healthcare, including using AI to ...